Off-treatment durability of antiviral response to nucleoside analogues in patients with chronic hepatitis B
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Off-treatment durability of antiviral response to nucleoside analogues in patients with chronic hepatitis B
Authors
Keywords
Chronic hepatitis B, Nucleoside analogue, Durability, Hepatocellular carcinoma, HBs antigen
Journal
BMC GASTROENTEROLOGY
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-03-19
DOI
10.1186/s12876-016-0454-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
- (2015) JOURNAL OF HEPATOLOGY
- Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study
- (2014) Wai-Kay Seto et al. GUT
- When to stop nucleos(t)ide analogues treatment for chronic hepatitis B? Durability of antiviral response
- (2014) Wonseok Kang WORLD JOURNAL OF GASTROENTEROLOGY
- HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability
- (2013) Gi-Ae Kim et al. GUT
- Off-therapy durability of response to entecavir therapy in hepatitis B e antigen-negative chronic hepatitis B patients
- (2013) Wen-Juei Jeng et al. HEPATOLOGY
- Seroclearance rate of hepatitis B surface antigen in 2,112 patients with chronic hepatitis in Japan during long-term follow-up
- (2013) Mariko Kobayashi et al. JOURNAL OF GASTROENTEROLOGY
- Sustained Responses and Loss of HBsAg in HBeAg-Negative Patients With Chronic Hepatitis B Who Stop Long-Term Treatment With Adefovir
- (2012) Stephanos J. Hadziyannis et al. GASTROENTEROLOGY
- Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection
- (2012) Tetsuya Hosaka et al. HEPATOLOGY
- Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
- (2012) Yun-Fan Liaw et al. Hepatology International
- Clearance of hepatitis B surface antigen during long-term nucleot(s)ide analog treatment in chronic hepatitis B: results from a nine-year longitudinal study
- (2012) Tetsuya Hosaka et al. JOURNAL OF GASTROENTEROLOGY
- Long-term continuous entecavir therapy in nucleos(t)ide-naïve chronic hepatitis B patients
- (2012) Atsushi Ono et al. JOURNAL OF HEPATOLOGY
- Durability of viral response after off-treatment in HBeAg positive chronic hepatitis B
- (2012) Myeong Jun Song WORLD JOURNAL OF GASTROENTEROLOGY
- A prospective clinical study in hepatitis B e antigen-negative chronic hepatitis B patients with stringent cessation criteria for adefovir
- (2011) Minghao Ha et al. ARCHIVES OF VIROLOGY
- Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naïve patients with a partial virological response
- (2011) Roeland Zoutendijk et al. HEPATOLOGY
- Nucleos(t)ide Analogues Only Induce Temporary Hepatitis B e Antigen Seroconversion in Most Patients With Chronic Hepatitis B
- (2010) Jurriën G.P. Reijnders et al. GASTROENTEROLOGY
- Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B
- (2010) Ting-Tsung Chang et al. HEPATOLOGY
- Poor durability of lamivudine effectiveness despite stringent cessation criteria: A prospective clinical study in hepatitis B e antigen-negative chronic hepatitis B patients
- (2010) Feng Liu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Clinical Efficacy of a 24-months Course of Lamivudine Therapy in Patients with HBeAg Negative Chronic Hepatitis B: A Long-term Prospective Study
- (2010) Yong Han Paik et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- The Duration of Lamivudine Therapy for Chronic Hepatitis B: Cessation vs. Continuation of Treatment After HBeAg Seroconversion
- (2009) James Fung et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B
- (2009) Hyun Woong Lee et al. HEPATOLOGY
- Chronic hepatitis B: Update 2009
- (2009) Anna S. F. Lok et al. HEPATOLOGY
- Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B*
- (2009) R. G. Gish et al. JOURNAL OF VIRAL HEPATITIS
- Stringent cessation criterion results in better durability of lamivudine treatment: a prospective clinical study in hepatitis B e antigen-positive chronic hepatitis B patients
- (2009) L. Wang et al. JOURNAL OF VIRAL HEPATITIS
- Meta-analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma
- (2008) J. J. Y. SUNG et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search